Scholarlink

Background <p>Tendomodulin (<i>TNMD</i>) is pivotal in various malignancies, including colorectal cancer (CRC). However, its comprehensive impact across cancers, particularly its immunomodulatory function in CRC, remains underexplored. This study explored the role of <i>TNMD</i> in CRC by focusing on its immunomodulatory functions through comprehensive molecular and clinical analyses.</p> Methods <p>Multiple bioinformatics databases and analytical tools were utilized for the <i>TNMD</i> in pan-cancer analysis. To validate the role of <i>TNMD</i> in CRC, we performed experiments, including immunofluorescence (IF), immunohistochemistry (IHC), real-time quantitative reverse transcription PCR (qPCR), western blotting, and cell migration assays.</p> Results <p><i>TNMD</i> expression and gene mutation vary across cancers and offer high diagnostic value. Survival analysis found that <i>TNMD</i> is associated with prognosis in multiple cancers. Notably, in patients with high microsatellite instability (MSI-H) CRC, <i>TNMD</i> expression correlated positively with various immune cells, particularly natural killer (NK) cells, whereas it was inversely correlated with regulatory T cells (Tregs). Crucially, in patients with microsatellite stability (MSS) CRC, high <i>TNMD</i> expression was associated with better immunotherapy outcomes, indicating its potential as a biomarker for patient stratification and tailored treatment approaches. Furthermore, single-cell sequencing data revealed stronger interactions between <i>TNMD</i>-positive tumor cells and fibroblasts or macrophages in the tumor microenvironment. Finally, <i>TNMD</i> was overexpressed in CRC tumor tissues and cell lines, thereby promoting invasion and metastasis.</p> Conclusions <p>Our findings reveal a critical immunomodulatory role of <i>TNMD</i> in CRC, particularly in influencing tumor–immune interactions. Beyond its potential diagnostic and prognostic biomarker, <i>TNMD</i> promotes CRC metastasis and invasion, thus emerging as a promising therapeutic target. These findings highlight <i>TNMD</i>’s significance in CRC and potentially other malignancies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Tendomodulin in pan-cancer analysis: exploring its impact on immune modulation and uncovering functional insights in colorectal cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年2月11日

查看全文
  • Jingfeng Chen,
  • Qin Hu,
  • Cong Zhang,
  • Aiqi Zhao,
  • Bihua Guan,
  • Yifan Wang,
  • Min Zhang,
  • Xia Li,
  • Biao Chen,
  • Lulu Zeng,
  • Minjiang Chen,
  • Bing Wu,
  • Jianping Wang,
  • Yang Yang,
  • Jiansong Ji

摘要

Background

Tendomodulin (TNMD) is pivotal in various malignancies, including colorectal cancer (CRC). However, its comprehensive impact across cancers, particularly its immunomodulatory function in CRC, remains underexplored. This study explored the role of TNMD in CRC by focusing on its immunomodulatory functions through comprehensive molecular and clinical analyses.

Methods

Multiple bioinformatics databases and analytical tools were utilized for the TNMD in pan-cancer analysis. To validate the role of TNMD in CRC, we performed experiments, including immunofluorescence (IF), immunohistochemistry (IHC), real-time quantitative reverse transcription PCR (qPCR), western blotting, and cell migration assays.

Results

TNMD expression and gene mutation vary across cancers and offer high diagnostic value. Survival analysis found that TNMD is associated with prognosis in multiple cancers. Notably, in patients with high microsatellite instability (MSI-H) CRC, TNMD expression correlated positively with various immune cells, particularly natural killer (NK) cells, whereas it was inversely correlated with regulatory T cells (Tregs). Crucially, in patients with microsatellite stability (MSS) CRC, high TNMD expression was associated with better immunotherapy outcomes, indicating its potential as a biomarker for patient stratification and tailored treatment approaches. Furthermore, single-cell sequencing data revealed stronger interactions between TNMD-positive tumor cells and fibroblasts or macrophages in the tumor microenvironment. Finally, TNMD was overexpressed in CRC tumor tissues and cell lines, thereby promoting invasion and metastasis.

Conclusions

Our findings reveal a critical immunomodulatory role of TNMD in CRC, particularly in influencing tumor–immune interactions. Beyond its potential diagnostic and prognostic biomarker, TNMD promotes CRC metastasis and invasion, thus emerging as a promising therapeutic target. These findings highlight TNMD’s significance in CRC and potentially other malignancies.